1 Min Read
* FDA ACCEPTANCE OF MEDICINES360’S FILING FOR SUPPLEMENTAL NEW DRUG APPLICATION FOR LILETTA® (LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM) 52 MG Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.